iShares Screened WS Intl Eq Idx E&E2
BLK4380AU
iShares Screened WS Intl Eq Idx E&E2 BLK4380AU Strategy
We believe that replication is the most appropriate investment strategy to track the performance of the Index as risk relative to the Index is minimised. Portfolios automatically rebalance, which minimises turnover and trading costs. Our replication approach aims to replicate as closely as possible the constituents of the Index, while considering transaction costs.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
funds
Chart of the Week: The role of semiliquid funds in your portfolio
Understanding their purpose, requirements and application for investors.
funds
Why this US fund manager says AI threatens to destroy company moats
Only one of the five classic moat pillars has predictive power today, says Westwood’s Adrian Helfert.
funds
Blue Owl offers a harsh lesson for semiliquid fund investors
Analyzing the saga of this US private credit BDC.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,851.50 | 18.00 | 0.20% |
| CAC 40 | 7,974.49 | 38.52 | 0.49% |
| DAX 40 | 23,730.92 | 166.91 | 0.71% |
| Dow JONES (US) | 46,993.26 | 46.85 | 0.10% |
| FTSE 100 | 10,403.60 | 85.91 | 0.83% |
| HKSE | 25,825.08 | 43.46 | -0.17% |
| NASDAQ | 22,479.53 | 105.35 | 0.47% |
| Nikkei 225 | 55,165.11 | 1,464.72 | 2.73% |
| NZX 50 Index | 13,315.60 | 133.37 | 1.01% |
| S&P 500 | 6,716.09 | 16.71 | 0.25% |
| S&P/ASX 200 | 8,644.90 | 18.70 | 0.22% |
| SSE Composite Index | 4,033.62 | 16.29 | -0.40% |